Cargando…
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal
BACKGROUND/AIMS: We studied the role of lysyl oxidase-like 2 (LOXL2) in collagen crosslinking and hepatic progenitor cell (HPC) differentiation, and the therapeutic efficacy of a LOXL2-blocking monoclonal antibody on liver fibrosis progression/reversal in mice. METHODS: Anti-LOXL2 antibody, control...
Autores principales: | Ikenaga, Naoki, Peng, Zhen-Wei, Vaid, Kahini A, Liu, Susan B, Yoshida, Shuhei, Sverdlov, Deanna Y, Mikels-Vigdal, Amanda, Smith, Victoria, Schuppan, Detlef, Popov, Yury V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561383/ https://www.ncbi.nlm.nih.gov/pubmed/28073888 http://dx.doi.org/10.1136/gutjnl-2016-312473 |
Ejemplares similares
-
Lysyl oxidase–like 2 (LOXL2)–mediated cross-linking of tropoelastin
por: Schmelzer, Christian E. H., et al.
Publicado: (2019) -
Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state
por: Zhang, Xi, et al.
Publicado: (2018) -
Wnt signaling and Loxl2 promote aggressive osteosarcoma
por: Matsuoka, Kazuhiko, et al.
Publicado: (2020) -
2-Aminomethylene-5-sulfonylthiazole
Inhibitors
of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying
Tumor Growth
por: Smithen, Deborah A., et al.
Publicado: (2019) -
The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis
por: Peng, Zhen‐Wei, et al.
Publicado: (2017)